| Financial Year |
March 31 2023 |
| Monetary Funds |
1,985,217,410.49 |
| Held-for-trading Financial Assets |
549,225,662.81 |
| Notes Receivable |
71,326,323.48 |
| Accounts Receivable |
798,303,149.92 |
| Advances to Suppliers |
531,924,443.84 |
| Other Receivables |
47,290,253.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,279,417,929.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
221,000,000.00 |
| Other Current Assets |
295,850,650.83 |
| Total Current Assets |
5,790,144,077.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
90,931,676.63 |
| Investment Properties |
272,577,791.71 |
| Fixed Assetes |
477,324,463.02 |
| Under-construction Projects |
51,674,945.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,394,200.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,972,961.36 |
| Deferred Income Tax Assets |
18,172,930.06 |
| Other Non-Current Assets |
2,010,174.57 |
| Sub-Total of Non-Current Assets |
2,012,896,245.85 |
| Total Assets |
7,803,040,323.75 |
| Short-Term Loans |
205,553,958.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
440,830,009.08 |
| Accounts Payable |
793,383,309.24 |
| Accounts Received In Advance |
3,955,771.01 |
| Employee Compensation Payable |
55,430,186.81 |
| Taxes Payable |
12,841,780.52 |
| Interest Payable |
-- |
| Dividend Payable |
4,322,272.00 |
| Other payables |
157,971,163.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
787,379.66 |
| Other Current Liabilities |
65,422,368.34 |
| Sub-Total of Current Liabilities |
2,303,758,836.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,300,000.00 |
| Deferred Income Tax Liabilities |
527,181.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,852,466.07 |
| Total Liabilities |
2,395,611,302.44 |
| Paid-In Capital(Or Share Stock) |
484,325,171.00 |
| Capital Surplus |
1,157,049,932.28 |
| Surplus Reserve |
261,293,425.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,440,748,368.05 |
| Minority Stockholder's Interest |
64,012,124.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,343,416,896.38 |
| Owner's Equity（Stockholder's Equity） |
5,407,429,021.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,803,040,323.75 |
